Cargando…
Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
BACKGROUND: Malignancy is a major cause of morbidity and mortality in transplant recipients. Identification of those at highest risk could facilitate pre-emptive intervention such as reduction of immunosuppression. Reduced circulating monocytic HLA-DR density is a marker of immune depression in the...
Autores principales: | Bottomley, Matthew J., Harden, Paul N., Wood, Kathryn J., Hester, Joanna, Issa, Fadi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283730/ https://www.ncbi.nlm.nih.gov/pubmed/35844527 http://dx.doi.org/10.3389/fimmu.2022.901273 |
Ejemplares similares
-
Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation
por: van Geffen, Chiel, et al.
Publicado: (2022) -
Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance
por: Zhang, Zhe (Jenny), et al.
Publicado: (2015) -
Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
por: Alzhrani, Alaa, et al.
Publicado: (2020) -
Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection
por: Yang, Feifei, et al.
Publicado: (2019) -
Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
por: Brook, Matthew Oliver, et al.
Publicado: (2022)